Clinical Outcomes of Dexmedetomidine As An Anesthetic Adjuvant in Intracranial Surgery, An Experience from Irfan General Hospital Peshawar: A Prospective Case Series Study

Authors

  • Shahid Mabood Hayatabad Medical Complex
  • Asad khan Hayatabad Medical Complex
  • Javed Iqbal Department of Anesthesiology and Pain Management MTI HMC, Peshawar, KPK, Pakistan
  • Fahad Mehmood Department of Anesthesiology and Pain Management MTI HMC, Peshawar, KPK, Pakistan
  • Abdul Haseeb Sahibzada Rehman College of Rehabilitation Sciences

DOI:

https://doi.org/10.36552/pjns.v27i2.857

Abstract

Objective:  Neuro anesthesia (most commonly general) is indicated in intracranial surgery, the goal of which is to maintain a stable hemodynamic environment. This study aimed at evaluating the effectiveness of Dexmedetomidine (DEX) when used as an adjuvant in intracranial surgery.

Materials And Methods:  A prospective design was utilized and the data was collected at the Department of Neurosurgery Irfan General Hospital Peshawar in patients undergoing intracranial. All those patients having a score of 14 or 15 on the Glasgow Coma Scale, and I and II on the American Society of Anesthesiologists (ASA) undergoing intracranial surgery under general anesthesia were included in the study.

Results:  The majority of patients were males 35 (66%) while 18 (34%) were females. 29(55%) patients were categorized as grade I while 24 (45%) as grade II according to the American Society of Anesthesiologists-Physical status. mean extubation time of our sample of patients undergoing craniotomy was 6.21 ± 2.16 minutes while the time for rescue analgesia was 41.23 ± 23.15 minutes. The heart rate values decreased significantly when noted at different intervals from the baseline.

Conclusion:  Dexmedetomidine is an effective and safe anesthetic adjuvant when used in intracranial surgery and provides stable hemodynamics both intra and post-operatively. The neuro anesthetic drug also reduces the requirements of other opioids and rescue drugs.

References

References:

Wang L, Shen J, Ge L, Arango MF, Tang X, Moodie J, et al. Dexmedetomidine for craniotomy under general anesthesia: a systematic review and meta-analysis of randomized clinical trials. Journal of clinical anesthesia. 2019;54:114-25.

Batra A, Verma R, Bhatia VK, Chandra G, Bhushan S. Dexmedetomidine as an Anesthetic Adjuvant in Intracranial Surgery. Anesthesia, essays and researches. 2017;11(2):309-13.

Mishra RK. Chapter 5 - Intravenous or inhalational anesthetics? In: Prabhakar H, editor. Essentials of Evidence-Based Practice of Neuroanesthesia and Neurocritical Care: Academic Press; 2022. p. 45-52.

Ibrahim IM, Hassan R. Efficacy of Dexmedetomidine Infusion Without Loading Dose on Hemodynamic Variables and Recovery Time During Craniotomy: A Randomized Double-blinded Controlled Study. 2021;11(2):e113410.

Carollo DS, Nossaman BD, Ramadhyani U. Dexmedetomidine: a review of clinical applications. Current Opinion in Anesthesiology. 2008;21(4):457-61.

Syrous NS, Sundstrøm T, Softeland E, Jammer I. Effects of Intraoperative Dexmedetomidine Infusion on Postoperative Pain after Craniotomy: A Narrative Review. 2021.

Tayari H, Bell A. Dexmedetomidine infusion as perioperative adjuvant in a dog undergoing craniotomy. Veterinary Record Case Reports. 2019;7(1):e000727.

Lin N, Vutskits L, Bebawy JF, Gelb AW. Perspectives on dexmedetomidine use for neurosurgical patients. Journal of Neurosurgical Anesthesiology. 2019;31(4):366-77.

Malviya S, Voepel?Lewis T, Tait AR, Merkel S, Tremper K, Naughton N. Depth of sedation in children undergoing computed tomography: validity and reliability of the University of Michigan Sedation Scale (UMSS). BJA: British Journal of Anaesthesia. 2002;88(2):241-5.

Lee SJKjoa. Dexmedetomidine: present and future directions. 2019;72(4):323-30.

Peng K, Wu S, Liu H, Ji F. Dexmedetomidine as an anesthetic adjuvant for intracranial procedures: Meta-analysis of randomized controlled trials. Journal of Clinical Neuroscience. 2014;21(11):1951-8.

Wang L, Shen J, Ge L, Arango MF, Tang X, Moodie J, et al. Dexmedetomidine for craniotomy under general anesthesia: a systematic review and meta-analysis of randomized clinical trials. 2019;54:114-25.

Ibrahim IM, Hassan R, Mostafa RH, Ibrahim MA. Efficacy of Dexmedetomidine Infusion Without Loading Dose on Hemodynamic Variables and Recovery Time During Craniotomy: A Randomized Double-blinded Controlled Study. Anesthesiology and pain medicine. 2021;11(2):e113410.

Castillo RL, Ibacache M, Cortínez I, Carrasco-Pozo C, Farías JG, Carrasco RA, et al. Dexmedetomidine improves cardiovascular and ventilatory outcomes in critically ill patients: basic and clinical approaches. 2020;10:1641.

Syrous NS, Sundstrøm T, Søfteland E, Jammer I. Effects of Intraoperative Dexmedetomidine Infusion on Postoperative Pain after Craniotomy: A Narrative Review. 2021;11(12):1636.

Downloads

Published

2023-06-09

Issue

Section

Original Articles